LEADER 04286nam 2200709 a 450 001 9910812000703321 005 20240516064728.0 010 $a9786613693785 010 $a9780470720080 010 $a0470720085 010 $a9781280783395 010 $a1280783397 010 $a9780470717769 010 $a0470717769 035 $a(CKB)1000000000688073 035 $a(SSID)ssj0000715089 035 $a(PQKBManifestationID)11414022 035 $a(PQKBTitleCode)TC0000715089 035 $a(PQKBWorkID)10700291 035 $a(PQKB)11483065 035 $a(MiAaPQ)EBC703850 035 $a(Au-PeEL)EBL703850 035 $a(CaPaEBR)ebr10575516 035 $a(CaONFJC)MIL369378 035 $a(OCoLC)797918308 035 $a(Perlego)2785157 035 $a(EXLCZ)991000000000688073 100 $a20750707d1974 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 14$aThe poisoned patient $ethe role of the laboratory 205 $a1st ed. 210 $aAmsterdam ;$aNew York $cElsevier$d1974 215 $aviii, 325 p. $cill 225 1 $aCiba Foundation symposium, new series ;$v26 (new ser.) 300 $aHeld at the Ciba Foundation 19th-21st February, 1974. 311 08$a9780470663189 311 08$a0470663189 311 08$a9789021940281 311 08$a9021940280 320 $aIncludes bibliographies and indexes. 327 $aIntro -- The Poisoned Patient: the role of the laboratory -- Contents -- Chairman's introduction -- The clinician's requirements from the laboratory in the treatment of the acutely poisoned patient -- Discussion -- The role of the laboratory in the treatment of narcotic poisoning -- Discussion -- Formation of reactive metabolites as a cause of drug toxicity -- Discussion -- Separation and detection of unstable metabolites of amphetamines, analgesics and phenothiazines -- Discussion -- Evaluation of chromatographic and spectroscopic procedures -- Discussion -- Use of gas chromatography-mass spectrometry in toxicological analysis -- Determination of cannabis components in blood -- Discussion of the two preceding papers -- Drug assay by radioactive reagents -- Discussion -- An on-line liquid chromatograph-mass spectrometer system -- Discussion -- Luminescence methods in drug analysis -- Discussion -- General Discussion I -- Immunoassay of drugs -- Immunological methods for detecting drugs: their application in the detection of digitoxin, digoxin and morphine -- Discussion of the two preceding papers -- Drug analysis in the overdosed patient -- Discussion -- The morbid anatomist's role in drug detection -- Discussion -- Drug-induced iatrogenic disease: the probability of its detection -- Discussion -- Limitations of haemodialysis and forced diuresis -- Discussion -- The poisoned patient: the clinician and the laboratory -- General Discussion II -- Precise analytical techniques -- Simple screening tests -- Research and its consequences -- Drug levels and individual variations -- Reporting the effectiveness of treatment -- Multiple drug abuse -- Screening for industrial chemicals -- Emergency toxicology: chemical requirements -- What the laboratory can do -- Other work of the laboratory -- Index of contributors -- Subject index. 330 8 $aThe Novartis Foundation Series is a popular collection of the proceedings from Novartis Foundation Symposia, in which groups of leading scientists from a range of topics across biology, chemistry and medicine assembled to present papers and discuss results. The Novartis Foundation, originally known as the Ciba Foundation, is well known to scientists and clinicians around the world. 410 0$aCiba Foundation symposium ;$vnew ser. 26. 606 $aPoisons$xAnalysis$vCongresses 606 $aDrugs$xToxicology$vCongresses 606 $aBody fluids$xAnalysis$vCongresses 615 0$aPoisons$xAnalysis 615 0$aDrugs$xToxicology 615 0$aBody fluids$xAnalysis 676 $a615.9/07 712 12$aSymposium on the Poisoned Patient: the Role of the Laboratory 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910812000703321 996 $aThe poisoned patient$92063642 997 $aUNINA